{
  "symbol": "AARTIDRUGS.NS",
  "period": "annual",
  "data": [
    {
      "ticker": "AARTIDRUGS.NS",
      "date": "2021-03-31",
      "quarter": "Q1 2021",
      "fiscal_year": 2021,
      "revenue": null,
      "gross_profit": null,
      "operating_income": null,
      "ebitda": null,
      "net_income": null,
      "diluted_eps": null,
      "total_assets": null,
      "total_liabilities": null,
      "total_equity": null,
      "total_debt": null,
      "cash_and_equivalents": null,
      "current_assets": null,
      "current_liabilities": null,
      "operating_cash_flow": null,
      "investing_cash_flow": null,
      "financing_cash_flow": null,
      "free_cash_flow": null,
      "capex": null,
      "pe_ratio": 18.838547,
      "peg_ratio": null,
      "pb_ratio": 2.757615,
      "ps_ratio": 1.5100992,
      "price_target_high": 597.0,
      "price_target_low": 597.0,
      "price_target_avg": 597.0,
      "promoter_holding": 0.60928,
      "institutional_holding": 0,
      "eps_estimate": null,
      "next_earnings_date": null,
      "last_buyback_date": null,
      "dividends": null,
      "splits": null,
      "buybacks": null,
      "debt_to_equity": null,
      "current_ratio": null,
      "operating_margin": null,
      "net_profit_margin": null,
      "roe": null,
      "roa": null,
      "debt_to_fcf_ratio": null,
      "ebitda_margin": null,
      "revenue_growth_yoy": null,
      "ebitda_growth_yoy": null
    },
    {
      "ticker": "AARTIDRUGS.NS",
      "date": "2022-03-31",
      "quarter": "Q1 2022",
      "fiscal_year": 2022,
      "revenue": 24886458000.0,
      "gross_profit": 5036626000.0,
      "operating_income": 2977969000.0,
      "ebitda": 3407520000.0,
      "net_income": 2050386000.0,
      "diluted_eps": null,
      "total_assets": 22079584000.0,
      "total_liabilities": 11716570000.0,
      "total_equity": 10363014000.0,
      "total_debt": 5428153000.0,
      "cash_and_equivalents": 216121000.0,
      "current_assets": 13933728000.0,
      "current_liabilities": 9400581000.0,
      "operating_cash_flow": 704140000.0,
      "investing_cash_flow": -1496399000.0,
      "financing_cash_flow": 920251000.0,
      "free_cash_flow": -815609000.0,
      "capex": -1519749000.0,
      "pe_ratio": 18.838547,
      "peg_ratio": null,
      "pb_ratio": 2.757615,
      "ps_ratio": 1.5100992,
      "price_target_high": 597.0,
      "price_target_low": 597.0,
      "price_target_avg": 597.0,
      "promoter_holding": 0.60928,
      "institutional_holding": 0,
      "eps_estimate": null,
      "next_earnings_date": null,
      "last_buyback_date": null,
      "dividends": null,
      "splits": null,
      "buybacks": null,
      "debt_to_equity": 0.5238006047275435,
      "current_ratio": 1.4822198755587555,
      "operating_margin": 11.96622275455993,
      "net_profit_margin": 8.238962732261859,
      "roe": 19.785614494007245,
      "roa": 9.286343438354635,
      "debt_to_fcf_ratio": null,
      "ebitda_margin": 13.692265890147967,
      "revenue_growth_yoy": null,
      "ebitda_growth_yoy": null
    },
    {
      "ticker": "AARTIDRUGS.NS",
      "date": "2023-03-31",
      "quarter": "Q1 2023",
      "fiscal_year": 2023,
      "revenue": 27055678000.0,
      "gross_profit": 4829691000.0,
      "operating_income": 2663495000.0,
      "ebitda": 3077995000.0,
      "net_income": 1663088000.0,
      "diluted_eps": null,
      "total_assets": 24213982000.0,
      "total_liabilities": 12287302000.0,
      "total_equity": 11926680000.0,
      "total_debt": 6089145000.0,
      "cash_and_equivalents": 75034000.0,
      "current_assets": 14917882000.0,
      "current_liabilities": 9494771000.0,
      "operating_cash_flow": 1333212000.0,
      "investing_cash_flow": -1639720000.0,
      "financing_cash_flow": 165422000.0,
      "free_cash_flow": -314966000.0,
      "capex": -1648178000.0,
      "pe_ratio": 18.838547,
      "peg_ratio": null,
      "pb_ratio": 2.757615,
      "ps_ratio": 1.5100992,
      "price_target_high": 597.0,
      "price_target_low": 597.0,
      "price_target_avg": 597.0,
      "promoter_holding": 0.60928,
      "institutional_holding": 0,
      "eps_estimate": null,
      "next_earnings_date": null,
      "last_buyback_date": null,
      "dividends": null,
      "splits": null,
      "buybacks": null,
      "debt_to_equity": 0.5105481994989385,
      "current_ratio": 1.5711681724603994,
      "operating_margin": 9.844495488155943,
      "net_profit_margin": 6.146909347457491,
      "roe": 13.944266132737692,
      "roa": 6.868296176977418,
      "debt_to_fcf_ratio": null,
      "ebitda_margin": 11.376521408925697,
      "revenue_growth_yoy": null,
      "ebitda_growth_yoy": null
    },
    {
      "ticker": "AARTIDRUGS.NS",
      "date": "2024-03-31",
      "quarter": "Q1 2024",
      "fiscal_year": 2024,
      "revenue": 25088708000.0,
      "gross_profit": 8508600000.0,
      "operating_income": 2777035000.0,
      "ebitda": 3204901000.0,
      "net_income": 1714182000.0,
      "diluted_eps": null,
      "total_assets": 24323580000.0,
      "total_liabilities": 11504037000.0,
      "total_equity": 12819543000.0,
      "total_debt": 5642800000.0,
      "cash_and_equivalents": 67427000.0,
      "current_assets": 13207199000.0,
      "current_liabilities": 7955427000.0,
      "operating_cash_flow": 3589232000.0,
      "investing_cash_flow": -2236508000.0,
      "financing_cash_flow": -1360331000.0,
      "free_cash_flow": 1325887000.0,
      "capex": -2263345000.0,
      "pe_ratio": 18.838547,
      "peg_ratio": null,
      "pb_ratio": 2.757615,
      "ps_ratio": 1.5100992,
      "price_target_high": 597.0,
      "price_target_low": 597.0,
      "price_target_avg": 597.0,
      "promoter_holding": 0.60928,
      "institutional_holding": 0,
      "eps_estimate": null,
      "next_earnings_date": null,
      "last_buyback_date": null,
      "dividends": null,
      "splits": null,
      "buybacks": null,
      "debt_to_equity": 0.44017169722820854,
      "current_ratio": 1.6601496060488017,
      "operating_margin": 11.068864128037204,
      "net_profit_margin": 6.832484159806077,
      "roe": 13.371631110406978,
      "roa": 7.047408317361178,
      "debt_to_fcf_ratio": 4.255867958581689,
      "ebitda_margin": 12.7742767782223,
      "revenue_growth_yoy": null,
      "ebitda_growth_yoy": null
    },
    {
      "ticker": "AARTIDRUGS.NS",
      "date": "2025-03-31",
      "quarter": "Q1 2025",
      "fiscal_year": 2025,
      "revenue": 23689276000.0,
      "gross_profit": 8449300000.0,
      "operating_income": 2431886000.0,
      "ebitda": 3034208000.0,
      "net_income": 1681585000.0,
      "diluted_eps": null,
      "total_assets": 25746782000.0,
      "total_liabilities": 12053354000.0,
      "total_equity": 13693428000.0,
      "total_debt": 6150707000.0,
      "cash_and_equivalents": 45772000.0,
      "current_assets": 13383550000.0,
      "current_liabilities": 8369668000.0,
      "operating_cash_flow": 2445838000.0,
      "investing_cash_flow": -1646308000.0,
      "financing_cash_flow": -821185000.0,
      "free_cash_flow": 674224000.0,
      "capex": -1771614000.0,
      "pe_ratio": 18.838547,
      "peg_ratio": null,
      "pb_ratio": 2.757615,
      "ps_ratio": 1.5100992,
      "price_target_high": 597.0,
      "price_target_low": 597.0,
      "price_target_avg": 597.0,
      "promoter_holding": 0.60928,
      "institutional_holding": 0,
      "eps_estimate": null,
      "next_earnings_date": null,
      "last_buyback_date": null,
      "dividends": null,
      "splits": null,
      "buybacks": null,
      "debt_to_equity": 0.44917218683298293,
      "current_ratio": 1.5990538692813143,
      "operating_margin": 10.26576751438077,
      "net_profit_margin": 7.098507358350672,
      "roe": 12.28023399254007,
      "roa": 6.531243399660587,
      "debt_to_fcf_ratio": 9.122646182870975,
      "ebitda_margin": 12.80836104910931,
      "revenue_growth_yoy": null,
      "ebitda_growth_yoy": null
    }
  ]
}